Na,K-ATPase as an Integrator of the Calcium-signaling Machinery
Na,K-ATP 酶作为钙信号传导机制的整合者
基本信息
- 批准号:7457662
- 负责人:
- 金额:$ 32.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:1,2-diacylglycerol1-Phosphatidylinositol 3-KinaseATP phosphohydrolaseAbbreviationsAffectBindingBiochemicalBiological AssayBlood PressureBlood VesselsCalciumCalcium SignalingCardiac GlycosidesCardiovascular DiseasesCardiovascular PhysiologyCaveolaeCell membraneCell physiologyComplexCyan Fluorescent ProteinCyclodextrinsCyclophosphamide/Fluorouracil/PrednisoneDiglyceridesDimethyl SuberimidateDisruptionDithiothreitolDominant-Negative MutationDoseEndocytosisEnzymesEpidermal Growth Factor ReceptorEpithelial CellsFamilyFluorescence Resonance Energy TransferFunctional disorderGeneticGreen Fluorescent ProteinsHeart DiseasesHypertensionITPR1 geneImageImage AnalysisIn VitroInositolIon ChannelIon PumpsKidneyKnock-in MouseLLC-PK1 CellsLaboratoriesLeadModelingMolecularNa(+)-K(+)-Exchanging ATPaseOuabainPH DomainPharmaceutical PreparationsPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositolsPhospholipase CPhosphotransferasesPhysiologyPlantsPlayPropionatesProtein KinaseProtein Kinase CProtein Tyrosine KinaseProteinsPurposeRNA InterferenceReactive Oxygen SpeciesReceptor Protein-Tyrosine KinasesRecruitment ActivityRegulationRenal functionReporterResearchResearch PersonnelRoleSarcoplasmic ReticulumSecond Messenger SystemsSignal TransductionSmall Interfering RNASodium ChlorideSystemTestingTherapeuticWorkbaseblood pressure regulationcrosslinkextracellularkidney cellknock-downnovel strategiespreventprogramsprotein protein interactionreceptorreceptor functionreceptors for activated C kinasered fluorescent proteinresponsesecond messengertime usetraffickingtripolyphosphate
项目摘要
DESCRIPTION (provided by applicant): Na/K-ATPase belongs to the family of P-type ATPases and was discovered as an energy transducing ion pump. A major difference between the Na/K-ATPase and other P-type ATPases is its ability to bind cardiotonic steroids (CIS) such as ouabain. While endogenous CTS regulate blood pressure via their effects on vasculature and renal salt handling, the plant-derived CTS have been used as drugs for more than 200 years. Recently, we have demonstrated that the Na/K-ATPase is an important receptor that resides in caveolae and interacts directly with Src, a non-receptor tyrosine kinase. We know now that the effects of low doses of ouabain on many cellular functions are not due to the simple inhibition of the ATPase; rather they require the activation of the Na/K-ATPase/Src receptor complex. In addition, the Na/K-ATPase contains multiple binding motifs (domains) and is capable of bringing Src and other signaling enzymes to their effectors such as ion channels. These findings have led the research field to look at the Na/K-ATPase not only as an ion pump, but also a classical receptor complex. This shift of the paradigm has brought about an important question: which regulatory purposes does this signaling Na/K-ATPase serve in regulation of cellular functions that are relevant to the physiology of endogenous CTS (e.g. blood pressure control)? This application is proposed to bridge this gap by studying the most likely target of this receptor complex, namely the Ca2+-signaling module because changes in intracellular Ca2+ are known to play a key role in regulation of vascular function and renal salt handling. Specifically, we will investigate how the Na/K-ATPase integrates multiple constituents into a functional Ca2+-signaling module in renal epithelial cells. We propose to use a combined biochemical, cellular, genetic and dynamic imaging approach to 1) define the molecular mechanism by which the Na/K-ATPase integrates Src/PLC-y/PKC and IPS receptor into a dynamic Ca2+ signaling module; 2) reveal whether disruption of the interaction between the Na/K-ATPase and IPS receptors affects IPS receptor trafficking and ouabain-induced Ca2+ signaling; And 3) identify the plasma membrane channel (s) that interacts with the Na/K-ATPase and is responsible for ouabain-induced Ca2+ influx. These studies will not only relate the newly discovered receptor function of the Na/K-ATPase to renal physiology of CTS, but also provide detailed mechanistic information on the formation of a Ca2+-signaling module that will eventually give us a new target for developing therapeutic approaches to renal and cardiovascular diseases involving dysfunction of intracellular Ca regulation. Calcium is a universal second messenger that plays an essential role in control of kidney and cardiovascular function. Abnormality in intracellular calcium regulation will lead to both kidney and heart diseases such as hypertension. We are using a simple model to dissect the formation of a very important calcium controlling system in kidney cells and to investigate how we can manipulate this system to eventually develop new approaches to prevent renal and cardiovascular diseases.
描述(由申请人提供):Na/k-ATPase属于P型ATPase家族,并被发现为能量转导离子泵。 Na/k-ATPase和其他P型ATPases之间的主要区别在于它结合源自肺类固醇(CI)(例如ouabain)的能力。虽然内源性CTS通过对脉管系统和肾脏盐处理的影响调节血压,但植物来源的CT已被用作药物已有200多年了。最近,我们证明了Na/k-ATPase是一种重要的受体,它位于小窝中,并直接与SRC(一种非受体酪氨酸激酶)相互作用。我们现在知道,低剂量的瓦巴因对许多细胞功能的影响并不是由于对ATPase的简单抑制作用。相反,它们需要激活Na/K-ATPase/SRC受体复合物。另外,Na/k-ATPase包含多个结合基序(域),并且能够将SRC和其他信号传导酶带到其效应子(例如离子通道)。这些发现导致研究领域不仅将Na/k-ATPase视为离子泵,而且是经典的受体复合物。范式的这种转移提出了一个重要的问题:该信号传导Na/k-ATPase在调节与内源性CTS生理学(例如血压控制)的细胞功能方面有哪些调节目的?提出了通过研究该受体复合物的最可能目标(即Ca2+信号模块)来弥合这一间隙的,因为已知细胞内Ca2+的变化在调节血管功能和肾脏盐处理方面起关键作用。具体而言,我们将研究NA/K-ATPase如何将多个成分整合到肾上皮细胞中的功能性CA2+信号模块中。我们建议使用合并的生化,细胞,遗传和动态成像方法1)定义Na/k-ATPase通过该分子机制将SRC/PLC-Y/PKC和IPS受体整合到动态CA2+信号模块中; 2)揭示Na/k-ATPase和IPS受体之间相互作用的破坏是否会影响IPS受体的运输以及Ouabain诱导的Ca2+信号传导; 3)确定与Na/k-ATPase相互作用的质膜通道,并负责Ouabain诱导的Ca2+流入。这些研究不仅将将Na/K-ATPase的新发现的受体功能与CTS的肾脏生理学联系起来,而且还提供了有关形成Ca2+信号模块形成的详细机械信息,最终将为我们提供针对肾血管疾病和心血管疾病的治疗方法的新目标,该疾病涉及涉及静脉内的CANELLUCTURCLUCTURCALUCTURCALUCTURCALUCTURCALUCTURCALUCTURCALUCTURCALUCTURCALULUCTUL CARUCTIOL CARUCTIOL CARUCTIOL CARUCTIOL。钙是一种通用的第二使者,在控制肾脏和心血管功能中起着至关重要的作用。细胞内钙调节的异常将导致肾脏和心脏病,例如高血压。我们正在使用一个简单的模型来剖析肾细胞中非常重要的钙控制系统的形成,并研究如何操纵该系统以最终开发新方法,以防止肾脏和心血管疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zijian Xie其他文献
Zijian Xie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zijian Xie', 18)}}的其他基金
Interaction of Na+/K+-ATPase With It's Signaling Partners
Na /K -ATP 酶与其信号传导伙伴的相互作用
- 批准号:
8250441 - 财政年份:2011
- 资助金额:
$ 32.37万 - 项目类别:
Interaction of Na+/K+-ATPase With It's Signaling Partners
Na /K -ATP 酶与其信号传导伙伴的相互作用
- 批准号:
7664209 - 财政年份:2009
- 资助金额:
$ 32.37万 - 项目类别:
Na,K-ATPase as an Integrator of the Calcium-signaling Machinery
Na,K-ATP 酶作为钙信号传导机制的整合者
- 批准号:
7267320 - 财政年份:2007
- 资助金额:
$ 32.37万 - 项目类别:
Na,K-ATPase as an Integrator of the Calcium-signaling Machinery
Na,K-ATP 酶作为钙信号传导机制的整合者
- 批准号:
7539561 - 财政年份:2007
- 资助金额:
$ 32.37万 - 项目类别:
Interactions of Na+/K+ ATPase with its signaling partners
Na /K ATP 酶与其信号伙伴的相互作用
- 批准号:
7464615 - 财政年份:2007
- 资助金额:
$ 32.37万 - 项目类别:
Na,K-ATPase as an Integrator of the Calcium-signaling Machinery
Na,K-ATP 酶作为钙信号传导机制的整合者
- 批准号:
7882673 - 财政年份:2007
- 资助金额:
$ 32.37万 - 项目类别:
Na,K-ATPase as an Integrator of the Calcium-signaling Machinery
Na,K-ATP 酶作为钙信号传导机制的整合者
- 批准号:
7653650 - 财政年份:2007
- 资助金额:
$ 32.37万 - 项目类别:
Interactions of Na+/K+ ATPase with its signaling partners
Na /K ATP 酶与其信号伙伴的相互作用
- 批准号:
7010371 - 财政年份:2005
- 资助金额:
$ 32.37万 - 项目类别:
相似海外基金
Host Ca2+, actin, and ATP production in rickettsia-endothelial cell dysfunction
立克次体内皮细胞功能障碍中宿主 Ca2、肌动蛋白和 ATP 的产生
- 批准号:
10509838 - 财政年份:2022
- 资助金额:
$ 32.37万 - 项目类别:
Exploiting proteotoxic stress in therapy-refractory HER2+ breast cancers
利用蛋白毒性应激治疗难治性 HER2 乳腺癌
- 批准号:
9269177 - 财政年份:2015
- 资助金额:
$ 32.37万 - 项目类别:
Exploiting proteotoxic stress in therapy-refractory HER2+ breast cancers
利用蛋白毒性应激治疗难治性 HER2 乳腺癌
- 批准号:
9061645 - 财政年份:2015
- 资助金额:
$ 32.37万 - 项目类别:
Interaction of Na+/K+-ATPase With It's Signaling Partners
Na /K -ATP 酶与其信号传导伙伴的相互作用
- 批准号:
8250441 - 财政年份:2011
- 资助金额:
$ 32.37万 - 项目类别:
Interaction of Na+/K+-ATPase With It's Signaling Partners
Na /K -ATP 酶与其信号传导伙伴的相互作用
- 批准号:
7664209 - 财政年份:2009
- 资助金额:
$ 32.37万 - 项目类别: